Ivabradine
Indication
Heart failure (NICE TA267), and chronic angina
NICE TA267 - Ivabradine for treating chronic heart failure
MHRA Drug Safety Update - Ivabradine and the risk of cardiac side effects
MHRA Drug Safety Update - Ivabradine: carefully monitor for bradycardia
Amber level 0
Brand:
Nice TA:
267
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Cardiovascular system
Background
LSCMMG is adopting the local decision made prior to April 2013
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: